Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | BCL2 | P10415 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.42 |
| ▸ | LDHA | P00338 | 2/20 | 0.37 |
| ▸ | LDHB | P07195 | 2/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29408625 | 1.00 | ALDH1A1 (0.52) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL23236496 | 0.85 | LMNA (0.48) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL28985909 | 0.81 | LMNA (0.54) | ALDH1A1MAPTGAALMNABCL2 | |
| SCHEMBL7863389 | 0.81 | LMNA (0.54) | ALDH1A1MAPTGAALMNABCL2 | |
| SCHEMBL1245081 | 0.80 | LMNA (0.42) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL23230285 | 0.80 | LMNA (0.44) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL574301 | 0.79 | ALDH1A1 (0.47) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL1433583 | 0.78 | ALDH1A1 (0.43) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL29692543 | 0.78 | ALDH1A1 (0.43) | ALDH1A1MAPTGAALMNACYP3A4 | |
| SCHEMBL28455007 | 0.76 | MAPT (0.49) | ALDH1A1MAPTGAALMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS CORP. | 2009-08-27 | — | — | US | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| EP-1879457-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-01-23 | — | — | EP | claimed |
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-04 | — | — | US | claimed |
| EP-1755381-A2 | ANTIMICROBIAL SILICON OXIDE FLAKES | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2007-02-28 | — | — | EP | claimed |
| WO-2006120135-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | claimed |
| WO-2005107456-A2 | ANTIMICROBIAL SILICON OXIDE FLAKES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-11-17 | — | — | WO | claimed |
| US-20050233930-A1 | Disinfectant cleaning compositions | RECKITT BENCKISER INC. (US) | 2005-10-20 | — | — | US | claimed |
| EP-1549730-A1 | DISINFECTANT CLEANING COMPOSITIONS | Reckitt Benckiser Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1549731-A1 | CLEANING AND DISINFECTING COMPOSITION | Reckitt Benckiser Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| EP-1537201-A1 | HARD SURFACE TREATING COMPOSITIONS | Reckitt Benckiser Inc. (US) | 2005-06-08 | — | — | EP | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| WO-2004035724-A1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004035723-A1 | DISINFECTANT CLEANING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2004024861-A1 | HARD SURFACE TREATING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-03-25 | — | — | WO | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | ALDH1A1 1412/4885MAPT 1445/4885GAA 204/4885 |
| US-20070231295-A1 | Antimicrobial Silicon Oxide Flakes | SIK2, SIK3, SIK1 | ALDH1A1 4610/4885MAPT 3891/4885GAA 2657/4885 |
| US-20090214606-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | ORAI3, PRF1, THPO | ALDH1A1 4731/4885MAPT 4811/4885GAA 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.